APA (7th ed.) Citation

SJ, B., LD, S., DL, G., LM, B., B, G., BL, L., . . . MC, A. (2004). Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice. Clinical immunology (Orlando, Fla.), 112(3), 273. https://doi.org/10.1016/j.clim.2004.04.006

Chicago Style (17th ed.) Citation

SJ, Banuelos, Shultz LD, Greiner DL, Burzenski LM, Gott B, Lyons BL, Rossini AA, and Appel MC. "Rejection of Human Islets and Human HLA-A2.1 Transgenic Mouse Islets by Alloreactive Human Lymphocytes in Immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) Mice." Clinical Immunology (Orlando, Fla.) 112, no. 3 (2004): 273. https://doi.org/10.1016/j.clim.2004.04.006.

MLA (9th ed.) Citation

SJ, Banuelos, et al. "Rejection of Human Islets and Human HLA-A2.1 Transgenic Mouse Islets by Alloreactive Human Lymphocytes in Immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) Mice." Clinical Immunology (Orlando, Fla.), vol. 112, no. 3, 2004, p. 273, https://doi.org/10.1016/j.clim.2004.04.006.